Phenylmethanethiol



Compound IDCDAMM00980
Common namePhenylmethanethiol
IUPAC namephenylmethanethiol
Molecular formulaC7H8S

Experimental data

Retention time0.26
Adduct[2M+K]+
Actual mz287.033
Theoretical mz287.033
Error1.25
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.0622

Identifiers and class information

Inchi keyUENWRTRMUIOCKN-UHFFFAOYSA-N
SmilesSCC=1C=CC=CC1
SuperclassBenzenoids
ClassBenzene and substituted derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)7
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)2
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)1
Molecular weight (mol_MW)124.2
Computed dipole moment(dipole)1.788
Total solvent accessible surface area (SASA)324.093
Hydrophobic component of SASA (FOSA)47.271
Hydrophilic component of SASA (FISA)0
Pie component of the SASA (PISA)200.1
Weakly polar component of the SASA (WPSA)76.722
Total solvent accesible volume (volume)489.734
Number of hydrogen bond donors (donorHB)0.8
Number of hydrogen bond acceptors (accptHB)0.5
Free energy of solvation of dipole (dip^2/V)0.0065263
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0013799
Globularity descriptor (glob)0.92712
Predicted polarizability in cubic angstroms (QPpolrz)14.072
Predicted hexadecane/gas partition coefficient (QPlogPC16)4.965
Predicted octanol/gas partition coefficient (QPlogPoct)5.523
Predicted water/gas partition coefficient (QPlogPw)3.11
Predicted octanol/water partition coefficient (QPlogPo/w)2.922
Predicted aqueous solubility (QPlogS)-2.388
Conformation-independent predicted aqueous solubility (CIQPlogS)-2.484
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.666
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)9906.04
Predicted brain/blood partition coefficient (QPlogBB)0.058
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)10000
Predicted skin permeability, log Kp (QPlogKp)-0.623
PM3 calculated ionization potential (IP(ev))9.196
PM3 calculated electron affinity (EA(eV))0.167
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)-0.267
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)0
Number of nitrogen and oxygen atoms (#NandO)0
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q16853AOC3Amine oxidase, copper containingT69619SEA
Q99720SIGMAR1Sigma opioid receptorT46360SEA
P15144ANPEPAminopeptidase NT67272SEA
P08473MMENeprilysinT05409SEA
Q96RJ0TAAR1Trace amine-associated receptor 1 (by homology)T99524SEA
Q05940SLC18A2Synaptic vesicular amine transporter (by homology)T48873SEA
P23141CES1Acyl coenzyme A:cholesterol acyltransferaseT76369SEA
P14902IDO1Indoleamine 2,3-dioxygenaseT89697SwissTargetPrediction and SEA
Q99685MGLLMonoglyceride lipaseT18664SEA
P15085CPA1Carboxypeptidase A1T33966SEA
Q99571P2RX4P2X purinoceptor 4T60330SEA
Q04609FOLH1Glutamate carboxypeptidase IIT97071SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T69619DI0190Hypertension[ICD-11: BA00-BA04]Q16853AOC3
T46360DI0105Cough[ICD-11: MD12]Q99720SIGMAR1
T67272DI0351Psoriasis[ICD-11: EA90]P15144ANPEP
T05409DI0175Heart failure[ICD-11: BD10-BD1Z]P08473MME
T99524DI0040Attention deficit hyperactivity disorder[ICD-11: 6A05]Q96RJ0TAAR1
T99524DI0149Focal/segmental autonomic disorder[ICD-11: 8D8A]Q96RJ0TAAR1
T99524DI0290Narcolepsy[ICD-11: 7A20]Q96RJ0TAAR1
T48873DI0079Choreiform disorder[ICD-11: 8A01]Q05940SLC18A2
T48873DI0125Dissociative neurological symptom disorder[ICD-11: 6B60]Q05940SLC18A2
T48873DI0129Dystonic disorder[ICD-11: 8A02]Q05940SLC18A2
T48873DI0137Essential hypertension[ICD-11: BA00]Q05940SLC18A2
T48873DI0190Hypertension[ICD-11: BA00-BA04]Q05940SLC18A2
T76369DI0335Peroxisomal disease[ICD-11: 5C57]P23141CES1
T76369DI0398Synthesis disorder[ICD-11: 5C52-5C59]P23141CES1
T89697DI0117Depression[ICD-11: 6A70-6A7Z]P14902IDO1
T18664DI0163General pain disorder[ICD-11: 8E43]Q99685MGLL
T18664DI0409Tic disorder[ICD-11: 8A05]Q99685MGLL
T97071DI0122Diagnostic imaging[ICD-11: N.A.]Q04609FOLH1
T97071DI0346Prostate cancer[ICD-11: 2C82]Q04609FOLH1

Copyright © 2025